A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1999
10/21/1999	WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999	WO1998041625A8 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
10/21/1999	WO1998020932A3 Conditioning for allogeneic stem cell transplantation
10/21/1999	DE19818598A1 New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents
10/21/1999	DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
10/21/1999	DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999	DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999	DE19816932A1 New dipeptide derivatives useful as neuropeptide Y agonists and/or antagonists for treating cardiovascular disorders, coronary, cerebral or renal vasospasms, obesity, bulimia and asthma
10/21/1999	DE19816915A1 New dipeptide derivatives useful as neuropeptide Y agonists and/or antagonists for treating cardiovascular disorders, coronary, cerebral or renal vasospasms, obesity, bulimia and asthma
10/21/1999	DE19816903A1 New dipeptide derivatives useful as neuropeptide Y agonists and/or antagonists for treating cardiovascular disorders, coronary, cerebral or renal vasospasms, obesity, bulimia and asthma
10/21/1999	DE19816496A1 New catalytically active subunit of human telomerase
10/21/1999	DE19816186A1 GDNF-kodierende DNA, Teile davon und GDNF-Varianten GDNF-coding DNA, parts thereof and GDNF variants
10/21/1999	DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999	CA2369172A1 Ste20-related protein kinases
10/21/1999	CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999	CA2327882A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999	CA2327807A1 Anti-bacterial protein extracts from seeds of marigold and paprika
10/21/1999	CA2327516A1 Programmed cell death and caspase-12
10/21/1999	CA2327431A1 Pharmaceutical composition
10/21/1999	CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999	CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999	CA2325658A1 Gene coding for heliomicine and use thereof
10/21/1999	CA2325629A1 Crystalline forms of 1s-[1alpha (2s,3r), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999	CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999	CA2325390A1 Human stanniocalcin and uses thereof to inhibit adipogenesis
10/21/1999	CA2325338A1 Conjugate vaccines for the prevention of dental caries
10/21/1999	CA2325332A1 Therapeutic agent for ngf
10/21/1999	CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999	CA2325057A1 Secreted proteins and polynucleotides encoding them
10/21/1999	CA2325010A1 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999	CA2324992A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999	CA2324988A1 Methods for treatment and prevention of infections
10/21/1999	CA2324981A1 Peptides
10/21/1999	CA2324870A1 Modified biological material
10/21/1999	CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999	CA2324363A1 Coated starch capsules and a process for producing them
10/21/1999	CA2323733A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/21/1999	CA2321181A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999	CA2294018A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/20/1999	EP0950713A2 Recombinant adenoviral vector for gene transfer
10/20/1999	EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999	EP0950708A2 Enhanced affinity hyaluronan binding peptides
10/20/1999	EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999	EP0950665A1 Modified physiologically active proteins and medicinal compositions containing the same
10/20/1999	EP0950663A1 Method for stabilizing useful proteins and useful protein compositions
10/20/1999	EP0950418A2 Composition for preventing or treating ischemic disease
10/20/1999	EP0950417A2 Treatment of skeletal disorders
10/20/1999	EP0950416A1 Preventive and/or therapeutic agent for cachexia
10/20/1999	EP0950415A1 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction
10/20/1999	EP0950414A1 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction
10/20/1999	EP0950406A2 Remedy for CAG repeat expansion diseases
10/20/1999	EP0950189A1 Brca1 associated protein (bap-1) and uses therefor
10/20/1999	EP0950110A1 Novel morphogen-responsive signal transducer and methods of use thereof
10/20/1999	EP0950105A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
10/20/1999	EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999	EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999	EP0950101A1 Secreted proteins and polynucleotides encoding them
10/20/1999	EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999	EP0950099A1 NOVEL flt-3 RECEPTOR AGONISTS
10/20/1999	EP0950098A1 Stable expression of triple helical proteins
10/20/1999	EP0950097A2 Compositions and methods for tumour therapy
10/20/1999	EP0950096A1 Anti-invasive and anti-angiogenic urokinase fragments and their use
10/20/1999	EP0950095A2 TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
10/20/1999	EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999	EP0950068A2 Collagen binding protein compositions and methods of use
10/20/1999	EP0950066A1 THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH LEUKOCYTE ADHESION INHIBITOR-1 (LAI-1), AND CHEMOKINE BETA-11 (Ck$g(b)-11)
10/20/1999	EP0950065A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
10/20/1999	EP0950063A1 Multiple branch peptide constructions
10/20/1999	EP0950060A1 Antisense inhibition of human adhesion molecules
10/20/1999	EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999	EP0949931A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
10/20/1999	EP0949923A1 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
10/20/1999	EP0949922A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors
10/20/1999	EP0949917A1 Substances and their uses
10/20/1999	EP0949914A1 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens and tumors
10/20/1999	EP0949910A1 Transmural drug delivery method and apparatus
10/20/1999	EP0949905A2 Injectable depot gel composition and method of preparing the composition
10/20/1999	EP0831867A4 Collagen-based delivery matrix
10/20/1999	EP0783318A4 Inhibitors of farnesyl-protein transferase
10/20/1999	EP0663958A4 Inhibition of cyst formation by cytoskeletal specific drugs.
10/20/1999	EP0628057B1 Use of a therapeutical COMPOSITION FOR THE TREATMENT OF THERMAL INJURY
10/20/1999	CN1232505A Nucleic acid sequences that encode cell growth regulatory protein and uses thereof
10/20/1999	CN1232503A Tumor necrosis factor related ligand
10/20/1999	CN1232501A Modified TIE-2 -receptor ligands
10/20/1999	CN1232500A Neuritin, a neurogene
10/20/1999	CN1232499A Human growth gene and short stature gene region
10/20/1999	CN1232498A Guanine exchange factor of RHO GTPase and nucleic acid encoding it
10/20/1999	CN1232470A GLP-1 derivs.
10/20/1999	CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999	CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999	CN1232402A Method and compositions for immunomodulation
10/20/1999	CN1232401A Anti-chlamydial methods and materials
10/20/1999	CN1232087A Polynucleotide molecules encoding neospora proteins
10/20/1999	CN1232038A New peptide compounds, process for their preparation and pharmaceutical compositions containing them
10/20/1999	CN1231918A Human immunization strengthening medicine
10/19/1999	US5969222 Corn inbred lines for dairy cattle feed
10/19/1999	US5969132 Macrocyclic difluorostatone derivatives useful as antiviral agents
10/19/1999	US5969126 GNRH-leukotoxin chimeras
10/19/1999	US5969125 Polynucleotideds that encode polypeptides that can be used to generate antibodies to prevent, treat, and reduce effects of disease
10/19/1999	US5969120 Dna molecule with synthetically mutated retinoblastoma gene encoding a mutated protein; therapy for a tumor cell with mutation in cyclin gene; antitumor agents

1 ... 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 ... 3163